These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3295324)

  • 1. [Evaluation of the FAB classification of acute leukemia].
    Takada K; Shibata H
    Rinsho Byori; 1987 Feb; 35(2):111-6. PubMed ID: 3295324
    [No Abstract]   [Full Text] [Related]  

  • 2. On the quest for lineage specific markers for the diagnosis of megakaryoblastic leukemia.
    Berridge MV; Fraser JK
    Blood Cells; 1989; 15(1):278-83. PubMed ID: 2930850
    [No Abstract]   [Full Text] [Related]  

  • 3. Usefulness of CD9 detection in the diagnosis of acute megakaryoblastic leukemia.
    Yatomi Y; Yoneyama A; Nakahara K
    Eur J Haematol; 2004 Mar; 72(3):229-30. PubMed ID: 14962244
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of FAB classification of acute leukemias in era of immunophenotyping.
    Sachdeva MU; Ahluwalia J; Das R; Varma N; Garewal G
    Indian J Pathol Microbiol; 2006 Oct; 49(4):524-7. PubMed ID: 17183842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reproducibility of the FAB classification and prognostic value of the principle cytologic characteristics in 147 cases of acute non-lymphoblastic leukemia].
    Sierra J; Brugués R; Ribera JM; Pérez-Vila E; Vives Corrons JL; Grañena A; Rozman C
    Sangre (Barc); 1986; 31(4):457-66. PubMed ID: 3787414
    [No Abstract]   [Full Text] [Related]  

  • 6. Realistic pathologic classification of acute myeloid leukemias.
    Arber DA
    Am J Clin Pathol; 2001 Apr; 115(4):552-60. PubMed ID: 11293903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis of acute leukemia in 70 cases--the application of FAB classification and its problem--(author's transl)].
    Tsuchiya T; Kumasaka K; Kawano K; Ohshima T; Kuwashima M
    Rinsho Ketsueki; 1981 Dec; 22(12):1897-908. PubMed ID: 7345178
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical and electron microscopic investigation of 3 cases of acute myelomegakaryocytic leukemia].
    Aoyagi Y; Maeda M; Kanayama M; Banba M; Hirose M; Enomoto Y
    Rinsho Ketsueki; 1987 Jun; 28(6):857-64. PubMed ID: 3478505
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of the FAB classification of acute leukemia].
    Ino T; Morishita Y; Matsui T; Shimizu S; Shigemura H; Nakamura K; Ono Y; Saito M; Okamoto M; Takada T
    Rinsho Ketsueki; 1984 Nov; 25(11):1788-95. PubMed ID: 6533322
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the Children's Oncology Group.
    Barnard DR; Alonzo TA; Gerbing RB; Lange B; Woods WG;
    Pediatr Blood Cancer; 2007 Jul; 49(1):17-22. PubMed ID: 16856158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunologic phenotype of acute leukemia, with reference to FAB classification of acute leukemia].
    Shimoyama M; Minato K; Tobinai K; Hirose M
    Rinsho Ketsueki; 1982 Jul; 23(7):1019-29. PubMed ID: 6982980
    [No Abstract]   [Full Text] [Related]  

  • 12. [Acute megakaryoblastic leukemia (M7). Immunocytochemical and ultrastructural study of 2 cases].
    Soler J; Brunet S; Bordes R; Rubiol E; Mitjavila M; Pujol-Moix N
    Med Clin (Barc); 1987 Jan; 88(2):68-70. PubMed ID: 3546975
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunological evaluation of FAB classification of acute leukemia].
    Takiguchi T; Konda S
    Rinsho Ketsueki; 1982 Jul; 23(7):1030-6. PubMed ID: 6958887
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute megakaryoblastic leukemia AML FAB-M7 in a patient 15 years after kidney transplantation.
    Scholze A; Blau IW; Tepel M
    Ann Hematol; 2011 Jul; 90(7):843-4. PubMed ID: 20857111
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cytology of acute leukemia].
    Imbert M; Jouault H; Tulliez M
    Rev Prat; 1996 Jan; 46(1):23-9. PubMed ID: 8596887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GATA1 as a new target to detect minimal residual disease in both transient leukemia and megakaryoblastic leukemia of Down syndrome.
    Pine SR; Guo Q; Yin C; Jayabose S; Levendoglu-Tugal O; Ozkaynak MF; Sandoval C
    Leuk Res; 2005 Nov; 29(11):1353-6. PubMed ID: 15916804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of FAB classification from cytomorphological and cytochemical view points].
    Tomonaga M
    Rinsho Ketsueki; 1982 Jul; 23(7):1003-8. PubMed ID: 6958885
    [No Abstract]   [Full Text] [Related]  

  • 18. [FAB classification of acute leukemia of children].
    Bessho F; Mizutani S; Kinumaki H; Kobayashi N
    Rinsho Ketsueki; 1984 Jun; 25(6):835-43. PubMed ID: 6592371
    [No Abstract]   [Full Text] [Related]  

  • 19. [Distribution of 159 cases of acute non-lymphoblastic leukaemia (ANLL) according to the FAB classification, and prognostic correlations (author's transl)].
    Sanz MA; Amigo V; Gomis F; Pérez Sirvent ML; Besalduch J; Rafecas J; Martinez J; Marty ML
    Sangre (Barc); 1981; 26(5-C):1019-25. PubMed ID: 7323923
    [No Abstract]   [Full Text] [Related]  

  • 20. [French-American-British (FAB) classification of acute leukemia].
    Amaki K
    Rinsho Ketsueki; 1982 Jul; 23(7):988-90. PubMed ID: 6958894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.